{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-021281","form_type":"8-K","ticker":"TLPH","cik":"0001427925","company_name":"TALPHERA, INC.","filed_at":"2023-08-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.895545+00:00","generated_at":"2026-06-12T17:38:15.325964+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"AcelRx reclassifies DSUVIA as discontinued in FY2022 10-K after March 2023 asset sale to Alora","bullets":["On March 12, 2023, AcelRx sold DSUVIA/DZUVEO assets to Vertical Pharmaceuticals (Alora) and classified the business as discontinued from Q1 2023.","2022 Form 10-K MD&A and financial statements restated to show DSUVIA as discontinued operations for all periods presented.","Continuing operations exclude DSUVIA; remaining business includes Zalviso, other pipeline, and collaboration revenue.","Restatement aligns with discontinued operations presentation in Q1 2023 10-Q; no other changes to 2022 10-K.","Cash, equivalents, and investments totaled $17.7M at December 31, 2022 (per restated balance sheet)."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-021281","json":"https://secwatch.observer/filing/0001437749-23-021281.json","markdown":"https://secwatch.observer/filing/0001437749-23-021281.md","text":"https://secwatch.observer/filing/0001437749-23-021281.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1427925/000143774923021281/0001437749-23-021281-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1427925/000143774923021281/acrx20230717_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T17:38:15.325964+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}